Semaglutide causes weight loss by mimicking a natural gut hormone called GLP-1, which signals your brain to feel full, slows down digestion, and improves how your body handles blood sugar. In the landmark STEP 1 clinical trial, people taking semaglutide lost an average of 14.9% of their body weight over 68 weeks, compared to just 2.4% with a placebo. That’s a striking difference, and it comes down to the drug working on multiple systems at once.
It Mimics a Hormone Your Body Already Makes
After you eat, your gut releases a hormone called GLP-1 (glucagon-like peptide-1). This hormone does several things: it tells your brain you’re satisfied, triggers insulin release to manage blood sugar, and slows digestion so nutrients absorb more gradually. The problem is that natural GLP-1 breaks down in your body within minutes.
Semaglutide is a modified version of GLP-1 that’s engineered to last much longer, roughly a full week. That’s why it’s taken as a once-weekly injection. Because it sticks around in your bloodstream, it keeps activating GLP-1 receptors throughout the body continuously rather than in brief bursts after meals.
How It Changes Your Appetite
The most powerful effect of semaglutide is on the brain. It targets two appetite systems simultaneously, creating what researchers at Northwestern University describe as a “double whammy” against hunger.
First, it activates neurons in the brainstem that generate feelings of fullness, the same ones that fire when your stomach is physically stretched after a big meal. Second, it silences a group of neurons in the hypothalamus called AgRP neurons. These neurons are your body’s hunger alarm system. When you lose weight, AgRP neurons normally ramp up activity to drive you to eat more, which is a major reason diets fail. Semaglutide suppresses that rebound hunger signal.
The result is that you feel genuinely less interested in food. People on semaglutide consistently report smaller portions feeling satisfying, reduced food cravings, and less mental preoccupation with eating. This isn’t willpower. It’s a neurological shift in how your brain processes hunger and fullness signals.
It Slows Down Your Digestion
Semaglutide also slows the rate at which food leaves your stomach, a process called gastric emptying. When food sits in your stomach longer, you feel physically full for a longer period after eating. This naturally leads to eating less at your next meal and snacking less between meals.
This effect is strongest in the first few weeks of treatment. After about 16 weeks of continuous use, the slowing of digestion becomes less pronounced, though it doesn’t fully return to normal. By that point, the brain-based appetite suppression is doing most of the heavy lifting for weight loss.
It Improves Blood Sugar Regulation
Semaglutide also changes how your body handles glucose, which has indirect effects on weight and energy balance. When your blood sugar rises after a meal, the drug amplifies your pancreas’s insulin response. Insulin moves sugar out of your bloodstream and into cells where it can be used for energy. This response is glucose-dependent, meaning it only kicks in when blood sugar is actually elevated, which reduces the risk of dangerous blood sugar drops.
At the same time, semaglutide suppresses glucagon, a hormone that tells your liver to release stored sugar into the bloodstream. By dialing down glucagon when it’s not needed, the drug helps prevent blood sugar spikes that can drive hunger and fat storage. This combination of better insulin response and lower glucagon output stabilizes energy levels throughout the day, which for many people reduces the urge to snack or overeat.
What Weight Loss Looks Like Over Time
Semaglutide doesn’t produce dramatic overnight results. It starts working on appetite and digestion right away, but measurable weight loss typically becomes noticeable after the first two to four weeks. That’s partly because the dose starts low and gradually increases.
The standard approach begins at 0.25 mg per week for the first four weeks, with the dose increasing every four weeks until reaching the maintenance level (up to 2.4 mg weekly for weight management). This slow ramp-up helps your body adjust and minimizes side effects, particularly nausea.
Based on clinical trial data, the pace of weight loss follows a predictable curve. For the first six months, people lose roughly 2% of their body weight per month. After that, the rate slows to about 1% per month as the body approaches a new set point. Most of the total weight loss, averaging around 15%, occurs by week 68. The weight doesn’t come off in a straight line. Plateaus are normal and expected.
Side Effects and Safety Considerations
The most common side effects are gastrointestinal: nausea, vomiting, diarrhea, and constipation. These tend to be worst during dose increases and improve over time as your body adapts. The slow titration schedule exists specifically to manage this.
Semaglutide carries a boxed warning related to thyroid tumors. In animal studies, GLP-1 receptor stimulation caused growth in a specific type of thyroid cell (C-cells). For this reason, it’s contraindicated in people with a personal or family history of medullary thyroid cancer or a rare condition called multiple endocrine neoplasia type 2. A systematic review and meta-analysis found that the actual occurrence of pancreatic and thyroid cancers in people taking semaglutide was not significantly different from placebo in clinical trials, but the preclinical signal was concerning enough to warrant the warning.
Beyond Weight Loss
Semaglutide’s effects extend beyond the scale. In people with type 2 diabetes and established heart disease, it reduced the risk of major cardiovascular events (heart attack, stroke, or cardiovascular death) by 26%. It has also shown significant kidney-protective effects in people with type 2 diabetes and chronic kidney disease, reducing the combined risk of kidney function decline, kidney failure, and cardiovascular death by 24%. These benefits appear to come from the drug’s combined effects on blood sugar, inflammation, and metabolic function rather than from weight loss alone.